John Baldoni

John Baldoni, PhD has over 40 years of experience in the pharmaceutical industry, including 29 years at GSK R&D, with 11 years on its executive leadership team. He participated in the research and development of scores of commercial products. Dr. Baldoni’s most recent prior roles were SVP of GSK’s science and technology platforms, SVP of an in silico drug GSK discovery unit and CTO of a biotech startup. He conceptualized and is currently senior science advisor to the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium – an open membership, public/private partnership currently comprised of pharma, tech, Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, and the University of California, San Francisco.

Dr. Baldoni received his PhD in biological chemistry from Penn State University.